Stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults)

Document first published:
Page updated:
Topic:
,
Publication type:

Stereotactic ablative radiotherapy is recommended to be available as a routine commissioning treatment option for adults with low and intermediate risk localised prostate cancer who do not require androgen deprivation therapy as an alternative to moderately hypofractionated external beam radiotherapy within the criteria set out in this document.

 

 

Document

Clinical commissioning policy: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults)

Clinical commissioning policy: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults)

  • PDF
  • 412 KB
  • 15 pages

Document

Clinical panel report: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults) (18 December 2024)

Clinical panel report: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults) (18 December 2024)

  • PDF
  • 208 KB
  • 2 pages

Document

Clinical panel report: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults) (19 February 2025)

Clinical panel report: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults) (19 February 2025)

  • PDF
  • 101 KB
  • 2 pages

Document

Narrative summary of papers presented for review: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults)

Narrative summary of papers presented for review: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults)

  • PDF
  • 218 KB
  • 8 pages

Document

Clinical Priorities Advisory Group summary report: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults)

Clinical Priorities Advisory Group summary report: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults)

  • PDF
  • 263 KB
  • 11 pages

Document

Engagement report: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults)

Engagement report: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults)

  • PDF
  • 368 KB
  • 7 pages

Document

Equality and health inequalities impact assessment: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults)

Equality and health inequalities impact assessment: stereotactic ablative radiotherapy for the treatment of localised prostate cancer (adults)

  • PDF
  • 305 KB
  • 11 pages